nodes	percent_of_prediction	percent_of_DWPC	metapath
Amlexanox—Decreased Histamine Release—Olopatadine—allergic rhinitis	0.58	1	CiPCiCtD
Amlexanox—S100A12—Olopatadine—allergic rhinitis	0.178	0.5	CbGbCtD
Amlexanox—S100A13—Olopatadine—allergic rhinitis	0.178	0.5	CbGbCtD
Amlexanox—S100A12—nose—allergic rhinitis	0.00958	0.414	CbGeAlD
Amlexanox—IL3—Cytokines and Inflammatory Response—IL15—allergic rhinitis	0.00188	0.0694	CbGpPWpGaD
Amlexanox—IL3—Cytokines and Inflammatory Response—IL13—allergic rhinitis	0.00132	0.0488	CbGpPWpGaD
Amlexanox—S100A13—respiratory system—allergic rhinitis	0.00127	0.055	CbGeAlD
Amlexanox—S100A12—respiratory system—allergic rhinitis	0.00126	0.0543	CbGeAlD
Amlexanox—S100A13—eye—allergic rhinitis	0.00116	0.0503	CbGeAlD
Amlexanox—IL3—Cytokines and Inflammatory Response—IL5—allergic rhinitis	0.00113	0.0418	CbGpPWpGaD
Amlexanox—IL3—Interleukin receptor SHC signaling—IL5—allergic rhinitis	0.0011	0.0406	CbGpPWpGaD
Amlexanox—S100A13—epithelium—allergic rhinitis	0.00106	0.046	CbGeAlD
Amlexanox—S100A12—epithelium—allergic rhinitis	0.00105	0.0454	CbGeAlD
Amlexanox—S100A13—skin of body—allergic rhinitis	0.00101	0.0437	CbGeAlD
Amlexanox—IL3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—allergic rhinitis	0.000945	0.0349	CbGpPWpGaD
Amlexanox—Oropharyngeal pain—Olopatadine—allergic rhinitis	0.000849	0.0611	CcSEcCtD
Amlexanox—IL3—Cytokines and Inflammatory Response—IL10—allergic rhinitis	0.000828	0.0305	CbGpPWpGaD
Amlexanox—IL3—Hematopoietic Stem Cell Differentiation—IL5—allergic rhinitis	0.000827	0.0305	CbGpPWpGaD
Amlexanox—IL3—Cytokines and Inflammatory Response—IL4—allergic rhinitis	0.000805	0.0297	CbGpPWpGaD
Amlexanox—FGF1—respiratory system—allergic rhinitis	0.000784	0.0339	CbGeAlD
Amlexanox—IL3—Interleukin-3, 5 and GM-CSF signaling—IL5—allergic rhinitis	0.000766	0.0283	CbGpPWpGaD
Amlexanox—IL3—Calcium signaling in the CD4+ TCR pathway—IL4—allergic rhinitis	0.000761	0.0281	CbGpPWpGaD
Amlexanox—Throat sore—Flunisolide—allergic rhinitis	0.000747	0.0538	CcSEcCtD
Amlexanox—Oropharyngeal discomfort—Flunisolide—allergic rhinitis	0.00074	0.0533	CcSEcCtD
Amlexanox—IL3—Interleukin-2 signaling—IL5—allergic rhinitis	0.000727	0.0268	CbGpPWpGaD
Amlexanox—FGF1—eye—allergic rhinitis	0.000716	0.0309	CbGeAlD
Amlexanox—IL3—G beta:gamma signalling through PI3Kgamma—IL5—allergic rhinitis	0.000715	0.0264	CbGpPWpGaD
Amlexanox—IL3—GPVI-mediated activation cascade—IL5—allergic rhinitis	0.000703	0.0259	CbGpPWpGaD
Amlexanox—IL3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL5—allergic rhinitis	0.000692	0.0255	CbGpPWpGaD
Amlexanox—IL3—G-protein beta:gamma signalling—IL5—allergic rhinitis	0.000681	0.0251	CbGpPWpGaD
Amlexanox—S100A13—lung—allergic rhinitis	0.000676	0.0292	CbGeAlD
Amlexanox—S100A12—lung—allergic rhinitis	0.000667	0.0288	CbGeAlD
Amlexanox—FGF1—epithelium—allergic rhinitis	0.000655	0.0283	CbGeAlD
Amlexanox—FGF1—skin of body—allergic rhinitis	0.000623	0.0269	CbGeAlD
Amlexanox—Oropharyngeal pain—Flunisolide—allergic rhinitis	0.000592	0.0426	CcSEcCtD
Amlexanox—S100A12—DEx/H-box helicases activate type I IFN and inflammatory cytokines production—NFKB1—allergic rhinitis	0.000583	0.0215	CbGpPWpGaD
Amlexanox—Mouth ulceration—Cetirizine—allergic rhinitis	0.000495	0.0356	CcSEcCtD
Amlexanox—IL3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—allergic rhinitis	0.000492	0.0181	CbGpPWpGaD
Amlexanox—IL3—Cytokines and Inflammatory Response—CD4—allergic rhinitis	0.00047	0.0173	CbGpPWpGaD
Amlexanox—PDE4D—lung—allergic rhinitis	0.000445	0.0192	CbGeAlD
Amlexanox—PDE4B—respiratory system—allergic rhinitis	0.000442	0.0191	CbGeAlD
Amlexanox—FGF1—lung—allergic rhinitis	0.000416	0.018	CbGeAlD
Amlexanox—S100A12—RIP-mediated NFkB activation via ZBP1—NFKB1—allergic rhinitis	0.000397	0.0146	CbGpPWpGaD
Amlexanox—PDE4A—lung—allergic rhinitis	0.000394	0.017	CbGeAlD
Amlexanox—IL3—Signaling by Interleukins—IL5—allergic rhinitis	0.000374	0.0138	CbGpPWpGaD
Amlexanox—PDE4B—bronchus—allergic rhinitis	0.000364	0.0157	CbGeAlD
Amlexanox—S100A12—TRAF6 mediated NF-kB activation—NFKB1—allergic rhinitis	0.000357	0.0132	CbGpPWpGaD
Amlexanox—IL3—Cytokines and Inflammatory Response—TGFB1—allergic rhinitis	0.000337	0.0124	CbGpPWpGaD
Amlexanox—S100A12—ZBP1(DAI) mediated induction of type I IFNs—NFKB1—allergic rhinitis	0.000335	0.0123	CbGpPWpGaD
Amlexanox—S100A12—TAK1 activates NFkB by phosphorylation and activation of IKKs complex—NFKB1—allergic rhinitis	0.000335	0.0123	CbGpPWpGaD
Amlexanox—PDE4B—trachea—allergic rhinitis	0.000327	0.0141	CbGeAlD
Amlexanox—Throat sore—Triamcinolone—allergic rhinitis	0.000324	0.0233	CcSEcCtD
Amlexanox—Oropharyngeal discomfort—Triamcinolone—allergic rhinitis	0.000321	0.0231	CcSEcCtD
Amlexanox—Nervous system disorder—Desloratadine—allergic rhinitis	0.000316	0.0228	CcSEcCtD
Amlexanox—Stomatitis—Cetirizine—allergic rhinitis	0.000299	0.0215	CcSEcCtD
Amlexanox—Paraesthesia—Cyproheptadine—allergic rhinitis	0.000298	0.0214	CcSEcCtD
Amlexanox—Stomatitis—Flunisolide—allergic rhinitis	0.000294	0.0211	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Desloratadine—allergic rhinitis	0.000278	0.02	CcSEcCtD
Amlexanox—Nervous system disorder—Olopatadine—allergic rhinitis	0.00027	0.0195	CcSEcCtD
Amlexanox—IL3—Senescence and Autophagy in Cancer—SMAD3—allergic rhinitis	0.000269	0.00992	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—MS4A2—allergic rhinitis	0.000265	0.00977	CbGpPWpGaD
Amlexanox—Oropharyngeal pain—Triamcinolone—allergic rhinitis	0.000257	0.0185	CcSEcCtD
Amlexanox—Paraesthesia—Diphenhydramine—allergic rhinitis	0.000242	0.0174	CcSEcCtD
Amlexanox—Paraesthesia—Dimenhydrinate—allergic rhinitis	0.000242	0.0174	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Olopatadine—allergic rhinitis	0.000238	0.0171	CcSEcCtD
Amlexanox—Pain—Olopatadine—allergic rhinitis	0.000236	0.017	CcSEcCtD
Amlexanox—PDE4B—lung—allergic rhinitis	0.000235	0.0101	CbGeAlD
Amlexanox—IL3—Cytokine Signaling in Immune system—HLA-G—allergic rhinitis	0.000216	0.00798	CbGpPWpGaD
Amlexanox—IL3—Differentiation Pathway—TGFB1—allergic rhinitis	0.000213	0.00786	CbGpPWpGaD
Amlexanox—IL3—Platelet activation, signaling and aggregation—IL5—allergic rhinitis	0.000211	0.00777	CbGpPWpGaD
Amlexanox—IL3—IL-3 Signaling Pathway—TGFB1—allergic rhinitis	0.000209	0.00773	CbGpPWpGaD
Amlexanox—Headache—Cyproheptadine—allergic rhinitis	0.000208	0.015	CcSEcCtD
Amlexanox—Nervous system disorder—Loratadine—allergic rhinitis	0.000204	0.0147	CcSEcCtD
Amlexanox—Headache—Desloratadine—allergic rhinitis	0.000202	0.0145	CcSEcCtD
Amlexanox—Nausea—Cyproheptadine—allergic rhinitis	0.000197	0.0142	CcSEcCtD
Amlexanox—Nervous system disorder—Cetirizine—allergic rhinitis	0.000192	0.0138	CcSEcCtD
Amlexanox—Nausea—Desloratadine—allergic rhinitis	0.000191	0.0138	CcSEcCtD
Amlexanox—Paraesthesia—Loratadine—allergic rhinitis	0.000186	0.0134	CcSEcCtD
Amlexanox—S100A12—Innate Immune System—MS4A2—allergic rhinitis	0.00018	0.00664	CbGpPWpGaD
Amlexanox—Gastrointestinal disorder—Loratadine—allergic rhinitis	0.000179	0.0129	CcSEcCtD
Amlexanox—Pain—Loratadine—allergic rhinitis	0.000178	0.0128	CcSEcCtD
Amlexanox—Paraesthesia—Cetirizine—allergic rhinitis	0.000175	0.0126	CcSEcCtD
Amlexanox—IL3—Cytokine Signaling in Immune system—IL5—allergic rhinitis	0.000174	0.00643	CbGpPWpGaD
Amlexanox—Headache—Olopatadine—allergic rhinitis	0.000173	0.0124	CcSEcCtD
Amlexanox—Headache—Dimenhydrinate—allergic rhinitis	0.000169	0.0122	CcSEcCtD
Amlexanox—Headache—Diphenhydramine—allergic rhinitis	0.000169	0.0122	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Cetirizine—allergic rhinitis	0.000169	0.0121	CcSEcCtD
Amlexanox—Pain—Cetirizine—allergic rhinitis	0.000167	0.012	CcSEcCtD
Amlexanox—Pain—Flunisolide—allergic rhinitis	0.000164	0.0118	CcSEcCtD
Amlexanox—Nausea—Olopatadine—allergic rhinitis	0.000164	0.0118	CcSEcCtD
Amlexanox—Nervous system disorder—Montelukast—allergic rhinitis	0.000161	0.0116	CcSEcCtD
Amlexanox—Nausea—Diphenhydramine—allergic rhinitis	0.00016	0.0115	CcSEcCtD
Amlexanox—Nausea—Dimenhydrinate—allergic rhinitis	0.00016	0.0115	CcSEcCtD
Amlexanox—S100A12—Cytosolic sensors of pathogen-associated DNA—NFKB1—allergic rhinitis	0.000159	0.00586	CbGpPWpGaD
Amlexanox—Paraesthesia—Montelukast—allergic rhinitis	0.000147	0.0106	CcSEcCtD
Amlexanox—S100A12—TRAF6 Mediated Induction of proinflammatory cytokines—NFKB1—allergic rhinitis	0.000143	0.00529	CbGpPWpGaD
Amlexanox—Gastrointestinal disorder—Montelukast—allergic rhinitis	0.000141	0.0102	CcSEcCtD
Amlexanox—Pain—Montelukast—allergic rhinitis	0.00014	0.0101	CcSEcCtD
Amlexanox—S100A12—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—NFKB1—allergic rhinitis	0.000136	0.00502	CbGpPWpGaD
Amlexanox—IL3—Cytokine Signaling in Immune system—HLA-DQB1—allergic rhinitis	0.000135	0.00498	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.000134	0.00495	CbGpPWpGaD
Amlexanox—IL3—Signaling by Interleukins—NFKB1—allergic rhinitis	0.000134	0.00493	CbGpPWpGaD
Amlexanox—IL3—Immune System—MS4A2—allergic rhinitis	0.000131	0.00483	CbGpPWpGaD
Amlexanox—Headache—Loratadine—allergic rhinitis	0.00013	0.00937	CcSEcCtD
Amlexanox—S100A12—MyD88 cascade initiated on plasma membrane—NFKB1—allergic rhinitis	0.00013	0.00479	CbGpPWpGaD
Amlexanox—S100A12—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NFKB1—allergic rhinitis	0.000129	0.00474	CbGpPWpGaD
Amlexanox—S100A12—MyD88 dependent cascade initiated on endosome—NFKB1—allergic rhinitis	0.000126	0.00465	CbGpPWpGaD
Amlexanox—Nausea—Loratadine—allergic rhinitis	0.000123	0.00888	CcSEcCtD
Amlexanox—Headache—Cetirizine—allergic rhinitis	0.000122	0.00881	CcSEcCtD
Amlexanox—S100A12—Toll Like Receptor 9 (TLR9) Cascade—NFKB1—allergic rhinitis	0.000122	0.00449	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—PTGDR2—allergic rhinitis	0.000122	0.00449	CbGpPWpGaD
Amlexanox—Headache—Flunisolide—allergic rhinitis	0.00012	0.00866	CcSEcCtD
Amlexanox—S100A12—MyD88:Mal cascade initiated on plasma membrane—NFKB1—allergic rhinitis	0.00012	0.00442	CbGpPWpGaD
Amlexanox—Nausea—Cetirizine—allergic rhinitis	0.000116	0.00836	CcSEcCtD
Amlexanox—S100A12—MyD88-independent cascade—NFKB1—allergic rhinitis	0.000115	0.00424	CbGpPWpGaD
Amlexanox—Nausea—Flunisolide—allergic rhinitis	0.000114	0.00822	CcSEcCtD
Amlexanox—IL3—Senescence and Autophagy in Cancer—TGFB1—allergic rhinitis	0.000114	0.0042	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—IL5—allergic rhinitis	0.000109	0.00401	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.000105	0.00388	CbGpPWpGaD
Amlexanox—S100A12—Immune System—MS4A2—allergic rhinitis	0.000105	0.00387	CbGpPWpGaD
Amlexanox—S100A12—Activated TLR4 signalling—NFKB1—allergic rhinitis	0.000103	0.00381	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—MS4A2—allergic rhinitis	0.000103	0.00379	CbGpPWpGaD
Amlexanox—Headache—Montelukast—allergic rhinitis	0.000103	0.00739	CcSEcCtD
Amlexanox—IL3—Cytokine Signaling in Immune system—ICAM1—allergic rhinitis	9.85e-05	0.00363	CbGpPWpGaD
Amlexanox—FGF1—Differentiation Pathway—TGFB1—allergic rhinitis	9.75e-05	0.0036	CbGpPWpGaD
Amlexanox—Nausea—Montelukast—allergic rhinitis	9.73e-05	0.00701	CcSEcCtD
Amlexanox—S100A12—Toll Like Receptor 4 (TLR4) Cascade—NFKB1—allergic rhinitis	9.72e-05	0.00358	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—CYSLTR1—allergic rhinitis	9.55e-05	0.00352	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—CCL11—allergic rhinitis	9.23e-05	0.0034	CbGpPWpGaD
Amlexanox—Nervous system disorder—Hydrocortisone—allergic rhinitis	8.67e-05	0.00625	CcSEcCtD
Amlexanox—S100A12—Toll-Like Receptors Cascades—NFKB1—allergic rhinitis	8.65e-05	0.00319	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—PTGDR2—allergic rhinitis	8.59e-05	0.00317	CbGpPWpGaD
Amlexanox—IL3—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	8.47e-05	0.00312	CbGpPWpGaD
Amlexanox—Nervous system disorder—Methylprednisolone—allergic rhinitis	8.15e-05	0.00587	CcSEcCtD
Amlexanox—Paraesthesia—Prednisolone—allergic rhinitis	8.13e-05	0.00586	CcSEcCtD
Amlexanox—Paraesthesia—Hydrocortisone—allergic rhinitis	7.94e-05	0.00572	CcSEcCtD
Amlexanox—PDE4C—Signaling by GPCR—PTGDR2—allergic rhinitis	7.8e-05	0.00288	CbGpPWpGaD
Amlexanox—Pain—Prednisolone—allergic rhinitis	7.74e-05	0.00558	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	7.64e-05	0.0055	CcSEcCtD
Amlexanox—Pain—Hydrocortisone—allergic rhinitis	7.56e-05	0.00545	CcSEcCtD
Amlexanox—Paraesthesia—Triamcinolone—allergic rhinitis	7.48e-05	0.00539	CcSEcCtD
Amlexanox—PDE4D—GPCR downstream signaling—PTGDR2—allergic rhinitis	7.48e-05	0.00276	CbGpPWpGaD
Amlexanox—Paraesthesia—Methylprednisolone—allergic rhinitis	7.46e-05	0.00537	CcSEcCtD
Amlexanox—Nervous system disorder—Betamethasone—allergic rhinitis	7.41e-05	0.00534	CcSEcCtD
Amlexanox—Nervous system disorder—Dexamethasone—allergic rhinitis	7.41e-05	0.00534	CcSEcCtD
Amlexanox—IL3—GPCR downstream signaling—TAC1—allergic rhinitis	7.38e-05	0.00272	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—PTGDR2—allergic rhinitis	7.19e-05	0.00265	CbGpPWpGaD
Amlexanox—Pain—Triamcinolone—allergic rhinitis	7.12e-05	0.00513	CcSEcCtD
Amlexanox—PDE4A—GPCR downstream signaling—PTGDR2—allergic rhinitis	7.12e-05	0.00263	CbGpPWpGaD
Amlexanox—IL3—Immune System—HLA-G—allergic rhinitis	7.06e-05	0.00261	CbGpPWpGaD
Amlexanox—IL3—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	7.05e-05	0.0026	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—IL5—allergic rhinitis	6.86e-05	0.00253	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—PTGDR2—allergic rhinitis	6.79e-05	0.0025	CbGpPWpGaD
Amlexanox—Paraesthesia—Dexamethasone—allergic rhinitis	6.79e-05	0.00489	CcSEcCtD
Amlexanox—Paraesthesia—Betamethasone—allergic rhinitis	6.79e-05	0.00489	CcSEcCtD
Amlexanox—PDE4C—GPCR downstream signaling—CYSLTR1—allergic rhinitis	6.74e-05	0.00249	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—TAC1—allergic rhinitis	6.7e-05	0.00247	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—PTGDR2—allergic rhinitis	6.58e-05	0.00243	CbGpPWpGaD
Amlexanox—Gastrointestinal disorder—Betamethasone—allergic rhinitis	6.52e-05	0.0047	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	6.52e-05	0.0047	CcSEcCtD
Amlexanox—PDE4A—Signaling by GPCR—PTGDR2—allergic rhinitis	6.46e-05	0.00238	CbGpPWpGaD
Amlexanox—Pain—Dexamethasone—allergic rhinitis	6.46e-05	0.00465	CcSEcCtD
Amlexanox—Pain—Betamethasone—allergic rhinitis	6.46e-05	0.00465	CcSEcCtD
Amlexanox—IL3—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	6.28e-05	0.00232	CbGpPWpGaD
Amlexanox—IL3—Cytokine Signaling in Immune system—NFKB1—allergic rhinitis	6.24e-05	0.0023	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—IL5—allergic rhinitis	6.23e-05	0.0023	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—CYSLTR1—allergic rhinitis	6.12e-05	0.00226	CbGpPWpGaD
Amlexanox—FGF1—Immune System—MS4A2—allergic rhinitis	5.99e-05	0.00221	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—PTGDR2—allergic rhinitis	5.98e-05	0.00221	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—CCL11—allergic rhinitis	5.91e-05	0.00218	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—CYSLTR1—allergic rhinitis	5.87e-05	0.00216	CbGpPWpGaD
Amlexanox—IL3—Immune System—IL5—allergic rhinitis	5.69e-05	0.0021	CbGpPWpGaD
Amlexanox—Headache—Prednisolone—allergic rhinitis	5.67e-05	0.00409	CcSEcCtD
Amlexanox—S100A12—Immune System—HLA-G—allergic rhinitis	5.66e-05	0.00209	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CYSLTR1—allergic rhinitis	5.64e-05	0.00208	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—CYSLTR1—allergic rhinitis	5.58e-05	0.00206	CbGpPWpGaD
Amlexanox—PDE4D—Myometrial Relaxation and Contraction Pathways—NFKB1—allergic rhinitis	5.58e-05	0.00206	CbGpPWpGaD
Amlexanox—Headache—Hydrocortisone—allergic rhinitis	5.54e-05	0.00399	CcSEcCtD
Amlexanox—IL3—Signaling Pathways—CCL11—allergic rhinitis	5.45e-05	0.00201	CbGpPWpGaD
Amlexanox—Nausea—Prednisolone—allergic rhinitis	5.38e-05	0.00387	CcSEcCtD
Amlexanox—FGF1—Adaptive Immune System—HLA-G—allergic rhinitis	5.33e-05	0.00197	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—CYSLTR1—allergic rhinitis	5.33e-05	0.00197	CbGpPWpGaD
Amlexanox—Nausea—Hydrocortisone—allergic rhinitis	5.25e-05	0.00378	CcSEcCtD
Amlexanox—Headache—Triamcinolone—allergic rhinitis	5.22e-05	0.00376	CcSEcCtD
Amlexanox—Headache—Methylprednisolone—allergic rhinitis	5.21e-05	0.00375	CcSEcCtD
Amlexanox—PDE4B—GPCR downstream signaling—CYSLTR1—allergic rhinitis	5.17e-05	0.00191	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—CCL11—allergic rhinitis	5.15e-05	0.0019	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—CYSLTR1—allergic rhinitis	5.07e-05	0.00187	CbGpPWpGaD
Amlexanox—Nausea—Triamcinolone—allergic rhinitis	4.95e-05	0.00356	CcSEcCtD
Amlexanox—Nausea—Methylprednisolone—allergic rhinitis	4.94e-05	0.00355	CcSEcCtD
Amlexanox—PDE4B—Myometrial Relaxation and Contraction Pathways—NFKB1—allergic rhinitis	4.92e-05	0.00181	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—CCL11—allergic rhinitis	4.9e-05	0.00181	CbGpPWpGaD
Amlexanox—Headache—Betamethasone—allergic rhinitis	4.73e-05	0.00341	CcSEcCtD
Amlexanox—Headache—Dexamethasone—allergic rhinitis	4.73e-05	0.00341	CcSEcCtD
Amlexanox—PDE4C—GPCR downstream signaling—TAC1—allergic rhinitis	4.73e-05	0.00174	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—CYSLTR1—allergic rhinitis	4.69e-05	0.00173	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PTGDR2—allergic rhinitis	4.61e-05	0.0017	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IL5—allergic rhinitis	4.56e-05	0.00168	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—CCL11—allergic rhinitis	4.53e-05	0.00167	CbGpPWpGaD
Amlexanox—Nausea—Betamethasone—allergic rhinitis	4.49e-05	0.00323	CcSEcCtD
Amlexanox—Nausea—Dexamethasone—allergic rhinitis	4.49e-05	0.00323	CcSEcCtD
Amlexanox—IL3—Immune System—HLA-DQB1—allergic rhinitis	4.41e-05	0.00163	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—IL5—allergic rhinitis	4.4e-05	0.00162	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—allergic rhinitis	4.32e-05	0.00159	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—TAC1—allergic rhinitis	4.29e-05	0.00158	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	4.12e-05	0.00152	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—TAC1—allergic rhinitis	4.12e-05	0.00152	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PTGDR2—allergic rhinitis	4.01e-05	0.00148	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—IL5—allergic rhinitis	3.99e-05	0.00147	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TAC1—allergic rhinitis	3.96e-05	0.00146	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—TAC1—allergic rhinitis	3.92e-05	0.00145	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	3.88e-05	0.00143	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—IL5—allergic rhinitis	3.83e-05	0.00141	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PTGDR2—allergic rhinitis	3.82e-05	0.00141	CbGpPWpGaD
Amlexanox—FGF1—B Cell Activation—NFKB1—allergic rhinitis	3.82e-05	0.00141	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—TAC1—allergic rhinitis	3.74e-05	0.00138	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—IL5—allergic rhinitis	3.68e-05	0.00136	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—IL5—allergic rhinitis	3.64e-05	0.00134	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—TAC1—allergic rhinitis	3.63e-05	0.00134	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CYSLTR1—allergic rhinitis	3.62e-05	0.00133	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—TAC1—allergic rhinitis	3.56e-05	0.00131	CbGpPWpGaD
Amlexanox—S100A12—Immune System—HLA-DQB1—allergic rhinitis	3.53e-05	0.0013	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PTGDR2—allergic rhinitis	3.53e-05	0.0013	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CCL11—allergic rhinitis	3.49e-05	0.00129	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—IL5—allergic rhinitis	3.48e-05	0.00128	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—IL5—allergic rhinitis	3.37e-05	0.00124	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—HLA-DQB1—allergic rhinitis	3.33e-05	0.00123	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—IL5—allergic rhinitis	3.31e-05	0.00122	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PTGDR2—allergic rhinitis	3.29e-05	0.00122	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—TAC1—allergic rhinitis	3.29e-05	0.00121	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—CD4—allergic rhinitis	3.25e-05	0.0012	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—TGFB1—allergic rhinitis	3.24e-05	0.00119	CbGpPWpGaD
Amlexanox—FGF1—Immune System—HLA-G—allergic rhinitis	3.24e-05	0.00119	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	3.23e-05	0.00119	CbGpPWpGaD
Amlexanox—IL3—Immune System—ICAM1—allergic rhinitis	3.22e-05	0.00119	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CYSLTR1—allergic rhinitis	3.15e-05	0.00116	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—IL5—allergic rhinitis	3.06e-05	0.00113	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CCL11—allergic rhinitis	3.04e-05	0.00112	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CYSLTR1—allergic rhinitis	3e-05	0.00111	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CCL11—allergic rhinitis	2.89e-05	0.00107	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—NFKB1—allergic rhinitis	2.81e-05	0.00104	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—NFKB1—allergic rhinitis	2.8e-05	0.00103	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CYSLTR1—allergic rhinitis	2.77e-05	0.00102	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CCL11—allergic rhinitis	2.68e-05	0.000988	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL5—allergic rhinitis	2.61e-05	0.000962	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—SMAD3—allergic rhinitis	2.59e-05	0.000956	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CYSLTR1—allergic rhinitis	2.58e-05	0.000953	CbGpPWpGaD
Amlexanox—S100A12—Immune System—ICAM1—allergic rhinitis	2.58e-05	0.000951	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TAC1—allergic rhinitis	2.54e-05	0.000936	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CCL11—allergic rhinitis	2.5e-05	0.000921	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—ICAM1—allergic rhinitis	2.43e-05	0.000896	CbGpPWpGaD
Amlexanox—IL3—Immune System—CD4—allergic rhinitis	2.36e-05	0.000872	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IL5—allergic rhinitis	2.36e-05	0.00087	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TAC1—allergic rhinitis	2.21e-05	0.000815	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TAC1—allergic rhinitis	2.1e-05	0.000776	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IL5—allergic rhinitis	2.05e-05	0.000757	CbGpPWpGaD
Amlexanox—IL3—Immune System—NFKB1—allergic rhinitis	2.04e-05	0.000751	CbGpPWpGaD
Amlexanox—FGF1—Immune System—HLA-DQB1—allergic rhinitis	2.02e-05	0.000745	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IL5—allergic rhinitis	1.95e-05	0.000721	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TAC1—allergic rhinitis	1.95e-05	0.000718	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CD4—allergic rhinitis	1.89e-05	0.000699	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—CD4—allergic rhinitis	1.86e-05	0.000686	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TAC1—allergic rhinitis	1.81e-05	0.000669	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IL5—allergic rhinitis	1.81e-05	0.000667	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—CD4—allergic rhinitis	1.79e-05	0.000659	CbGpPWpGaD
Amlexanox—FGF1—Disease—SMAD3—allergic rhinitis	1.69e-05	0.000625	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IL5—allergic rhinitis	1.69e-05	0.000622	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—SMAD3—allergic rhinitis	1.66e-05	0.000612	CbGpPWpGaD
Amlexanox—S100A12—Immune System—NFKB1—allergic rhinitis	1.63e-05	0.000602	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—NFKB1—allergic rhinitis	1.6e-05	0.000591	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—NFKB1—allergic rhinitis	1.54e-05	0.000567	CbGpPWpGaD
Amlexanox—FGF1—Immune System—ICAM1—allergic rhinitis	1.47e-05	0.000544	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—SMAD3—allergic rhinitis	1.45e-05	0.000533	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—SMAD3—allergic rhinitis	1.38e-05	0.000507	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—NFKB1—allergic rhinitis	1.32e-05	0.000486	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—SMAD3—allergic rhinitis	1.27e-05	0.00047	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—SMAD3—allergic rhinitis	1.19e-05	0.000438	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TGFB1—allergic rhinitis	1.1e-05	0.000405	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CD4—allergic rhinitis	1.08e-05	0.000399	CbGpPWpGaD
Amlexanox—FGF1—Disease—CD4—allergic rhinitis	1e-05	0.000369	CbGpPWpGaD
Amlexanox—FGF1—Immune System—NFKB1—allergic rhinitis	9.33e-06	0.000344	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—NFKB1—allergic rhinitis	8.44e-06	0.000311	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—NFKB1—allergic rhinitis	7.35e-06	0.000271	CbGpPWpGaD
Amlexanox—FGF1—Disease—TGFB1—allergic rhinitis	7.18e-06	0.000265	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TGFB1—allergic rhinitis	7.03e-06	0.000259	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—NFKB1—allergic rhinitis	6.99e-06	0.000258	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—NFKB1—allergic rhinitis	6.47e-06	0.000239	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TGFB1—allergic rhinitis	6.12e-06	0.000226	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—NFKB1—allergic rhinitis	6.03e-06	0.000223	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TGFB1—allergic rhinitis	5.82e-06	0.000215	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TGFB1—allergic rhinitis	5.39e-06	0.000199	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TGFB1—allergic rhinitis	5.02e-06	0.000185	CbGpPWpGaD
